SCHEMBL27384658

SCHEMBL27384658

CCc1cc2[nH]c(CNC(=O)N3CCOCC3)cc2cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.46
▸ MAPT P10636 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ CASP7 P55210 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ EPHX2 P34913 4/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NOS3 P29474 1/20 0.39
▸ NOS1 P29475 1/20 0.39
▸ MAPK8 P45983 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ POLB P06746 2/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.37
▸ IDH1 O75874 1/20 0.37
▸ TGFBR1 P36897 1/20 0.37
▸ USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384652 0.90 SMN1; SMN2 (0.41) HTTEPHX2SMN1; SMN2MAPK1HRH3
SCHEMBL27384356 0.83 SMN1; SMN2 (0.40) HTTMAPTMEN1KMT2AEPHX2
SCHEMBL27384661 0.82 EPHX2 (0.39) EPHX2SMN1; SMN2
SCHEMBL27385176 0.80 P2RX7 (0.39) SMN1; SMN2
SCHEMBL27382489 0.79 SMN1; SMN2 (0.47) HTTMAPTKDM4EALDH1A1HSD17B10
SCHEMBL27382554 0.78 MTNR1A (0.46) HTTMAPTKDM4EALDH1A1HSD17B10
SCHEMBL27384649 0.77 HTT (0.42) HTTMAPTKDM4EALDH1A1HSD17B10
SCHEMBL31408356 0.77 POLB (0.39) HTTMAPTKDM4EALDH1A1HSD17B10
SCHEMBL27383138 0.77 SMN1; SMN2 (0.45) HTTMAPTKDM4EALDH1A1HSD17B10
SCHEMBL27383947 0.76 RAB9A (0.55) HTTMAPTKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback